Drug class
Antiretroviral; nucleoside reverse transcriptase translocation inhibitor (NRTTI)
Mechanism of action
A deoxyadenosine nucleoside analogue converted intracellularly to islatravir-triphosphate. The active triphosphate inhibits HIV reverse transcriptase by blocking translocation after incorporation into viral DNA, producing immediate and delayed chain termination.
General use cases
- Used as part of the fixed-dose doravirine/islatravir antiretroviral regimen for HIV-1 infection in adults under the applicable product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
